Dermal Penetration Potential of Perfluorooctanoic Acid (PFOA) in Human and Mouse Skin

REFERENCES

• Anderson-Mahoney , P. , Kotlerman , J. , Takhar , H. , Gray , D. and Dahlgren , J. 2008 . Self-reported health effects among community residents exposed to perfluorooctanoate . N. Solut. , 18 : 129 – 43 .
   PubMedGoogle Scholar
• Anderson , S. E. , Butterworth , L. , Jackson , L. G. , Frasch , H. F. , Franko , J. and Meade , B. J. 2009 . Adjuvancy and immunosuppression: Mechanisms of immunomodulation following dermal exposure to PFOA in mice . Toxicologist , 108 : 467
   Google Scholar
• Arp , H. P. , Niederer , C. and Goss , K. U. 2006 . Predicting the partitioning behavior of various highly fluorinated compounds . Environ. Sci. Technol. , 40 : 7298 – 304 .
   PubMed Web of Science ®Google Scholar
• Barton , C. A. , Botelho , M. A. and Kaiser , M. A. 2007 . Solid vapor pressure and enthalpy of sublimation for perfluorooctanoic acid . J. Chem. Eng. Data , 53 : 7298 – 303 .
   Google Scholar
• Betts , K. S. 2007 . Perfluoroalkyl acids: What is the evidence telling us? . Environ. Health Perspect. , 115 : A250 – 56 .
   PubMed Web of Science ®Google Scholar
• Burns , D. C. , Ellis , D. A. , Li , H. , McMurdo , C. J. and Webster , E. 2008 . Experimental pKa determination for perfluorooctanoic acid (PFOA) and the potential impact of pKa concentration dependence on laboratory-measured partitioning phenomena and environmental modeling . Environ. Sci. Technol. , 42 : 9283 – 88 .
   PubMed Web of Science ®Google Scholar
• Calafat , A. M. , Needham , L. L. , Kuklenyik , Z. , Reidy , J. A. , Tully , J. S. , Aguilar-Villalobos , M. and Naeher , L. P. 2006 . Perfluorinated chemicals in selected residents of the American continent . Chemosphere , 63 : 490 – 96 .
   PubMed Web of Science ®Google Scholar
• Calafat , A. M. , Wong , L. Y. , Kuklenyik , Z. , Reidy , J. A. and Needham , L. L. 2007 . Polyfluoroalkyl chemicals in the U.S. population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and comparisons with NHANES 1999–2000 . Environ. Health Perspect. , 115 : 1596 – 602 .
   PubMed Web of Science ®Google Scholar
• Corsini , E. and Galli , C. L. 1998 . Cytokines and irritant contact dermatitis . Toxicol. Lett. , 102–103 : 277 – 82 .
   PubMed Web of Science ®Google Scholar
• DeWitt , J. C. , Copeland , C. B. and Luebke , R. W. 2009b . Suppression of humoral immunity by perfluorooctanoic acid is independent of elevated serum corticosterone concentration in mice . Toxicol. Sci. , 109 : 106 – 12 .
   PubMed Web of Science ®Google Scholar
• Dewitt , J. C. , Copeland , C. B. , Strynar , M. J. and Luebke , R. W. 2008 . Perfluorooctanoic acid-induced immunomodulation in adult C57BL/6J or C57BL/6N female mice . Environ. Health Perspect. , 116 : 644 – 50 .
   PubMed Web of Science ®Google Scholar
• DeWitt , J. C. , Shnyra , A. , Badr , M. Z. , Lovelss , S. E. , Hoban , D. , Frame , S. R. , Cunard , R. , Anderson , S. E. , Meade , B. J. , Peden-Adams , M. M. , Luebke , R. W. and Luster , M. I. 2009a . Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha . Crit. Rev. Toxicol. , 39 : 76 – 94 .
   PubMed Web of Science ®Google Scholar
• European Centre for the Validation of Alternative Methods. 2000 ESAC statement on the application of the EpiDerm human skin model for skin corrosivity testing. European Centre for the Validation of Alternative Methods. http://ecvam.jrc.ec.europa.eu/publication/ EpiDerm_statement.pdf (http://ecvam.jrc.ec.europa.eu/publication/ EpiDerm_statement.pdf)
   Google Scholar
• Fairley , K. J. , Purdy , R. , Kearns , S. , Anderson , S. E. and Meade , B. J. 2007 . Exposure to the immunosuppressant, perfluorooctanoic acid, enhances the murine IgE and airway hyperreactivity response to ovalbumin . Toxicol. Sci. , 97 : 375 – 83 .
   PubMed Web of Science ®Google Scholar
• Fasano , W. J. , Kennedy , G. L. , Szostek , B. , Farrar , D. G. , Ward , R. J. , Haroun , L. and Hinderliter , P. M. 2005 . Penetration of ammonium perfluorooctanoate through rat and human skin in vitro . Drug Chem. Toxicol. , 28 : 79 – 90 .
   PubMed Web of Science ®Google Scholar
• Frasch , H. F. and Barbero , A. M. 2005 . Application of solid-phase microextraction to in vitro skin permeation experiments: example using diethyl phthalate . Toxicol. In Vitro , 19 : 253 – 59 .
   PubMed Web of Science ®Google Scholar
• ICCVAM. 2002. ICCVAM Evaluation of EPISKINTM, EpiDermTM (EPI-200), and the rat skin transcutaneous electrical resistance (TER) assay: In vitro test methods for assessing the dermal corrosivity potential of chemicals. The Interagency Coordinating Committee on the Validation of Alternative Methods and the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicicological Methods. U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Environmental Health Sciences, NIH publication number 02-4502. http://iccvam. niehs.nih.gov/methods/dermal/epiderm.htm (http://iccvam. niehs.nih.gov/methods/dermal/epiderm.htm)
   Google Scholar
• Kaiser , M. A. , Dawson , B. J. , Barton , C. A. and Botelho , M. A. 2010 . Understanding potential exposure sources of perfluorinated carboxylic acids in the workplace . Ann. Occup. Hyg. , 54 : 915 – 22 .
   PubMed Web of Science ®Google Scholar
• Kennedy , G. L. , Butenhoff , J. L. , Olsen , G. W. , O'Connor , J.C , Seacat , A. M. , Perkins , R. G. , Biegel , L. B. , Murphy , S. R. and Farrar , D. G. 2004 . The toxicology of perfluorooctanoate . Crit. Rev. Toxicol. , 34 : 351 – 84 .
   PubMed Web of Science ®Google Scholar
• Kudo , N. and Kawashima , Y. 2003 . Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals . J. Toxicol. Sci. , 28 : 49 – 57 .
   PubMedGoogle Scholar
• Kuklenyik , Z. , Needham , L. L. and Calafat , A. M. 2005 . Measurement of 18 perfluorinated organic acids and amides in human serum using on-line solid-phase extraction . Anal. Chem. , 77 : 6085 – 91 .
   PubMed Web of Science ®Google Scholar
• Liu , X. , Testa , B. and Fahr , A. 2010 . Lipophilicity and its relationship with passive drug permeation . Pharm. Res. , 28 : 962 – 77 .
   PubMed Web of Science ®Google Scholar
• Moussion , C. , Ortega , N. and Girard , J. P. 2008 . The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: A novel ‘alarmin'? . PLoS One , 3 : e3331
   PubMed Web of Science ®Google Scholar
• Olsen , G. W. , Burris , J. M. , Ehresman , D. J. , Froehlich , J. W. , Seacat , A. M. , Butenhoff , J. L. and Zobel , L. R. 2007 . Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers . Environ. Health Perspect. , 115 : 1298 – 305 .
   PubMed Web of Science ®Google Scholar
• Ping , J. , Rodgers , P. J. and Ameniya , S. 2009 . High lipophilicity of perfluoroalkyl carboxylate and solfonate: Implications for their membrane permeability . J. Am. Chem. Soc. , 131 : 2290 – 96 .
   PubMed Web of Science ®Google Scholar
• Rayne , S. and Forest , K. 2009 . Perfluoroalkyl sulfonic and carboxylic acids: A critical review of physicochemical properties, levels and patterns in waters and wastewaters, and treatment methods . J. Environ. Sci. Health A Tox. Hazard. Subst. Environ. Eng. , 44 : 1145 – 99 .
   PubMed Web of Science ®Google Scholar
• Sabourin , C. L. , Petrali , J. P. and Casillas , R. P. 2000 . Alterations in inflammatory cytokine gene expression in sulfur mustard-exposed mouse skin . J. Biochem. Mol. Toxicol. , 14 : 291 – 302 .
   PubMed Web of Science ®Google Scholar
• Shinoda , K. , Hato , M. and Hayashi , T. 1972 . Physicochemical properties of aqueous solutions of fluorinated surfactants . J. Phys. Chem. , 76 : 909 – 14 .
   Web of Science ®Google Scholar
• Shore , P. A. , Brodie , B. B. and Hogben , C. A. 1957 . The gastric secretion of drugs: A pH partition hypothesis . J. Pharmacol. Exp. Ther. , 119 : 361 – 69 .
   PubMed Web of Science ®Google Scholar
• U.S. Environmental Protection Agency. 2006. Revised draft hazard assessment of perfluorooctanoic acid and its salts. Office of Pollution Prevention and Toxics, Risk Assessment Division. http://www.epa.gov/sab/pdf/sab_06_006.pdf (http://www.epa.gov/sab/pdf/sab_06_006.pdf)
   Google Scholar
• Vecchia , B. E. and Bunge , A. L. 2003 . “ Skin absorption databases and predictive equations ” . In Transdermal drug delivery , 2nd , Edited by: Guy , R. H. and Hadgraft , J . 59 – 63 . New York : Marcel Dekker .
   Google Scholar
• Wittmann , M. , Macdonald , A. and Renne , J. 2009 . IL-18 and skin inflammation . Autoimmun. Rev. , 9 : 45 – 48 .
   PubMed Web of Science ®Google Scholar
• Yang , Q. , Abedi-Valugerdi , M. , Xie , Y. , Zhao , X. Y. , Möller , G , Nelson , B. D. and DePierre , J. W. 2002 . Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid . Int. Immunopharmacol. , 2 : 389 – 97 .
   PubMed Web of Science ®Google Scholar
• Yang , Q. , Xie , Y. , Eriksson , A. M. , Nelson , B. D. and DePierre , J. W. 2001 . Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice . Biochem. Pharmacol. , 62 : 1133 – 40 .
   PubMed Web of Science ®Google Scholar